Therapeutic Strategies Including Avastin as 1st Line Therapy in Elderly Patients Suffering From Advanced (IIIB/IV Stage) Non-squamous Non-small Cell Lung Cancer, in Routine Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2018
Price : $35 *
At a glance
- Drugs Bevacizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms AVANTAGE
- Sponsors Roche
- 23 Mar 2018 Status changed from active, no longer recruiting to completed.
- 02 Jan 2018 Planned End Date changed from 1 Dec 2017 to 28 Feb 2018.
- 23 Nov 2017 Planned End Date changed from 6 Oct 2017 to 1 Dec 2017.